Cool Caps Industries IPO vs Evoq Remedies IPO

Comparison between Cool Caps Industries IPO and Evoq Remedies IPO.

IPO Details

Cool Caps Industries IPO is a SME Fixed Price IPO proposed to list at NSE SME while Evoq Remedies IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Cool Caps Industries IPO is up to ₹11.04 Cr whereas the issue size of the Evoq Remedies IPO is up to ₹9.23 Cr. The final issue price of Cool Caps Industries IPO is ₹38.00 per share and of Evoq Remedies IPO is ₹27.00 per share.

 Cool Caps Industries IPOEvoq Remedies IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹36.00 per share
Issue Price (Upper)₹38.00 per share
Issue Price (Final)₹38.00 per share₹27.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size3000 shares4000 shares
Fresh Issue Size29,04,000 shares34,20,000 shares
Fresh Issue Size (Amount)up to ₹11.04 Crup to ₹9.23 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total29,04,000 shares34,20,000 shares
Issue Size Total (Amount)up to ₹11.04 Crup to ₹9.23 Cr

IPO Timetable

Cool Caps Industries IPO opens on Mar 10, 2022, while Evoq Remedies IPO opens on Mar 17, 2022. The closing date of Cool Caps Industries IPO and Evoq Remedies IPO is Mar 15, 2022, and Mar 22, 2022, respectively.

 Cool Caps Industries IPOEvoq Remedies IPO
Issue OpenMar 10, 2022Mar 17, 2022
Issue CloseMar 15, 2022Mar 22, 2022
Basis Of Allotment (Tentative)Mar 21, 2022Mar 25, 2022
Initiation of Refunds (Tentative)Mar 22, 2022Mar 28, 2022
Credit of Share (Tentative)Mar 23, 2022Mar 29, 2022
Listing date (Tentative)Mar 24, 2022Mar 30, 2022

Financials & KPIs

Cool Caps Industries IPO P/E ratio is 16.38, as compared to Evoq Remedies IPO P/E ratio of 33.75.

 Cool Caps Industries IPOEvoq Remedies IPO
Financials

Company Financials (Restated Standalone)

Period Ended30 Sep 202131 Mar 202131 Mar 202031 Mar 2019
Assets52.1948.7538.6020.84
Total Income18.8731.3025.7519.20
Profit After Tax1.332.923.211.37
EBITDA3.837.386.223.43
NET Worth17.6316.3013.385.63
Reserves and Surplus9.137.804.881.63
Total Borrowing28.8227.1821.8211.61
Amount in ₹ Crore

Company Financials (Restated)

Period Ended10 Feb 202231 Mar 202131 Mar 202031 Mar 2019
Assets26.618.055.652.15
Total Income10.5710.029.073.25
Profit After Tax0.940.710.000.01
EBITDA1.250.950.000.02
NET Worth13.280.740.020.02
Reserves and Surplus3.280.730.010.01
Total Borrowing5.730.010.010.00
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100%99.99%
Promoter Shareholding (Post-Issue)73.53%73.53%
P/E Ratio16.3833.75
Market Cap₹43.93 Cr.₹36.72 Cr.
EPS₹3.43₹10.05
RoNW17.996.94

Shares Offered

In the Cool Caps Industries IPO Retail Individual Investors (RII) are offered 14,52,000 shares while in Evoq Remedies IPO retail investors are offered 14,52,000 shares. Qualified Institutional Buyers (QIB) are offered in Cool Caps Industries IPO and in Evoq Remedies IPO.

 Cool Caps Industries IPOEvoq Remedies IPO
Market Maker Reservation1,56,000 shares1,80,000 shares
NII14,52,000 shares17,10,000 shares
RII14,52,000 shares17,10,000 shares
Total29,04,000 shares34,20,000 shares

Bids Received (Subscription)

Cool Caps Industries IPO subscribed 7.91x in total, whereas Evoq Remedies IPO subscribed 1.67x.

 Cool Caps Industries IPOEvoq Remedies IPO
NII (times)4.57x0.30x
RII (times)11.25x3.03x
Total (times)7.91x1.67x

Compare with others

Compare: